The sacral chordoma margin

Autor: Radaelli, Stefano, Fossati, P., Stacchiotti, Silvia, Akiyama, T., Asencio, J. M., Bandiera, S., Boglione, A., Boland, P., Bolle, S., Bruland, Ø., Brunello, Antonella, Bruzzi, Paolo, Campanacci, D., Cananzi, F., Capanna, R., Casadei, R., Cordoba, Abel, Court, C., Dei Tos, Angelo Paolo, Delaney, T., Paoli, A. de, Pas, T. M. de, Desai, A., Brina, L. di, Donati, Davide María, Fabbri, N., Fiore, M. R., Frezza, Anna M., Gambarotti, Marco, Gasbarrini, A., Georg, P., Grignani, Giovanni, Hindi, Nadia, Hug, E. B., Jones, Rebecca, Kawai, Akira, Krol, A. D., Grange, F. le, Luzzati, A., Marquina, G., Martin-Benlloch, J. A., Mazzocco, K., Navarria, F., Parchi, P. D., Patel, S., Pennacchioli, E., Petrongari, M. G., Picci, Piero, Pollock, R., Porcu, L., Quagliuolo, V., Sangalli, C., Scheipl, S., Scotto, G. M., Spalek, M., Steinmeier, T., Timmermann, B., Trama, A., Uhl, Matthias, Valverde, Claudia M., Varga, P. P., Verges, R., Weber, D. C., Zoccali, C., Casali, Paolo G., Sommer, J., Gronchi, Alesandro

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname

[Objective]: Aim of the manuscript is to discuss how to improve margins in sacral chordoma. [Background]: Chordoma is a rare neoplasm, arising in half cases from the sacrum, with reported local failure in >50% after surgery. [Methods]: A multidiscipl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fba09d8e4cc2b327305b03e30bcb61c7
http://hdl.handle.net/10261/238489

Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic.

Autor: Martin-Broto J; Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain., Hindi N; Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain., Aguiar S Jr; Department of Pelvic Surgery, A.C. Camargo Cancer Center, São Paulo, Brazil., Badilla-González R; Department of medical oncology, Rafael Ángel Calderón Guardia Hospital, San José, Costa Rica., Castro-Oliden V; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Chacón M; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Correa-Generoso R; Radiotherapy Department, Virgen de la Victoria University Hospital, Málaga, Spain., de Álava E; Pathology Department, University Hospital Virgen del Rocío, Seville, Spain.; CIBERONC, Madrid, Spain.; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Donati DM; Unit of Orthopedic Pathology and Osteoarticular Tissue Regeneration, Rizzoli Orthopedic Institute, Bologna, Italy., Eriksson M; Department of Medical Oncology, Skane University Hospital-Lund, Lund, Sweden., Falla-Jimenez M; Department of Breast and Soft Tissues Surgery, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., German G; Department of Medical Oncology, Hospital Oncológico Provincial, Córdoba, Argentina., Gobo Silva ML; Department of Radiation Therapy, A.C. Camargo Cancer Center, São Paulo, Brazil., Gouin F; Department of Orthopedic Surgery, Centre León Bérard, Lyon, France., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Haro-Varas JC; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Jiménez-Brenes N; Department of Medical Oncology, San Vicente de Paúl Hospital, Heredia, Costa Rica., Kasper B; Department of Medical Oncology, Mannheim University Medical Center, Mannheim, Germany., Lopes de Mello CA; Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil., Maki R; Department of Medical Oncology, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Martínez-Delgado P; Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain., Martínez-Said H; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico., Martinez-Tlahuel JL; Department of Surgery, Instituto Nacional de Cancerología, Mexico City, Mexico., Morales-Pérez JM; Radiology Department, University Hospital Virgen del Rocio, Seville, Spain., Muñoz-Casares FC; Department of Surgery, University Hospital Virgen del Rocio, Seville, Spain., Nakagawa SA; Department of Orthopedics, A.C. Camargo Cancer Center, São Paulo, Brazil., Ortiz-Cruz EJ; Orthopedic Surgery and Traumatology Department, La Paz University Hospital, Madrid, Spain., Palmerini E; Department of Medical Oncology, Rizzoli Orthopedic Institute, Bologna, Italy., Patel S; Department of Melanoma Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA., Moura DS; Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain., Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Sunyach MP; Department of Radiation Therapy, Centre León Bérard, Lyon, France., Valverde CM; Department of Medical Oncology, Vall d'Hebron Hospital, Barcelona, Spain., Waisberg F; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Blay JY; Department of Medical Oncology, Centre León Bérard, Lyon, France.

Publikováno v: The oncologist [Oncologist] 2020 Oct; Vol. 25 (10), pp. e1562-e1573. Date of Electronic Publication: 2020 Sep 23.